Pancreatic Cancer Research

ResearcherHarold C. Simmons Comprehensive Cancer CenterNo recent work listed

David Jonathan Sher

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3943-7480; OpenAlex author ID A5011724315. Sources: ClinicalTrials.gov.

Their work

Papers
2 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper, 1 trial

Papers 2

  1. Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma. Last author DOI 10.6004/jnccn.2019.7322↗
  2. Impact of Concurrent Medication Use on Pancreatic Cancer Survival-SEER-Medicare Analysis. Co-author DOI 10.1097/coc.0000000000000359↗

Trials 1

  1. Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer Principal investigator NCT03536182↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Muhammad Shaalan Beg · 2 shared papers, 2018–2019 · strength 0.18
  2. John C. Mansour · 1 shared paper, 2019 · strength 0.10
  3. Nina Niu Sanford · 1 shared paper, 2019 · strength 0.10
  4. Todd Anthony Aguilera · 1 shared paper, 2019 · strength 0.10
  5. Herbert J. Zeh · 1 shared paper, 2019 · strength 0.10
  6. Eric M. Mortensen · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.